BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 12244890)

  • 41. [The situation of patients with dementia may be rectified by Ginkgo biloba. Results of a health services research study concerning the ability of patients with dementia, quality of life of the nursing family members and total treatment costs].
    Heinen-Kammerer T; Motzkat K; Daniel D; Gertz HJ; Koller M; Lorenz W; Pilartz H; Zimmer B; Habs M; von den Driesch V; Rychlik R
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():127-33. PubMed ID: 16261949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P
    J Clin Epidemiol; 2003 Apr; 56(4):367-76. PubMed ID: 12767414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function.
    Curtis-Prior P; Vere D; Fray P
    J Pharm Pharmacol; 1999 May; 51(5):535-41. PubMed ID: 10411212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Protective effects of a Ginkgo biloba extract (EGb 761) on ischemia-reperfusion injury].
    Clostre F
    Therapie; 2001; 56(5):595-600. PubMed ID: 11806299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
    Mix JA; Crews WD
    J Altern Complement Med; 2000 Jun; 6(3):219-29. PubMed ID: 10890330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C.
    Bastianetto S; Zheng WH; Quirion R
    J Neurochem; 2000 Jun; 74(6):2268-77. PubMed ID: 10820186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
    Mix JA; Crews WD
    Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: a randomized controlled trial].
    Zhao MX; Dong ZH; Yu ZH; Xiao SY; Li YM
    Zhong Xi Yi Jie He Xue Bao; 2012 Jun; 10(6):628-34. PubMed ID: 22704410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications.
    DeFeudis FV; Drieu K
    Curr Drug Targets; 2000 Jul; 1(1):25-58. PubMed ID: 11475535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761
    Kandiah N; Ong PA; Yuda T; Ng LL; Mamun K; Merchant RA; Chen C; Dominguez J; Marasigan S; Ampil E; Nguyen VT; Yusoff S; Chan YF; Yong FM; Krairit O; Suthisisang C; Senanarong V; Ji Y; Thukral R; Ihl R
    CNS Neurosci Ther; 2019 Feb; 25(2):288-298. PubMed ID: 30648358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF).
    Smith PF; Maclennan K; Darlington CL
    J Ethnopharmacol; 1996 Mar; 50(3):131-9. PubMed ID: 8691847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease.
    Zimmermann M; Colciaghi F; Cattabeni F; Di Luca M
    Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):613-23. PubMed ID: 12396071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type].
    Haase J; Halama P; Hörr R
    Z Gerontol Geriatr; 1996; 29(4):302-9. PubMed ID: 8974721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].
    Schreiter Gasser U; Gasser T
    Fortschr Med Orig; 2001 Nov; 119(3-4):135-8. PubMed ID: 11789125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
    Schneider LS; DeKosky ST; Farlow MR; Tariot PN; Hoerr R; Kieser M
    Curr Alzheimer Res; 2005 Dec; 2(5):541-51. PubMed ID: 16375657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
    Kudolo GB
    J Clin Pharmacol; 2001 Jun; 41(6):600-11. PubMed ID: 11402628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ginkgo Biloba for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yang G; Wang Y; Sun J; Zhang K; Liu J
    Curr Top Med Chem; 2016; 16(5):520-8. PubMed ID: 26268332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Ginkgo--myth and reality].
    Z'Brun A
    Praxis (Bern 1994); 1995 Jan; 84(1):1-6. PubMed ID: 7839037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial.
    Scripnikov A; Khomenko A; Napryeyenko O;
    Wien Med Wochenschr; 2007; 157(13-14):295-300. PubMed ID: 17704975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [System evaluation on Ginkgo Biloba extract in the treatment of acute cerebral infarction].
    Wang L; Zhang T; Bai K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 40(10):1096-102. PubMed ID: 26541843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.